(Q42167575)

17 October 2017

Effectiveness of statin titration on low-density lipoprotein cholesterol goal attainment in patients at high risk of atherogenic events (English)

1 reference

17 October 2017

1 reference

1 reference

5

Leona E Markson

1 reference

17 October 2017

6

Charles M Alexander

1 reference

17 October 2017

Kathleen A Foley

1

1 reference

17 October 2017

Ross J Simpson

series ordinal

2

1 reference

17 October 2017

John R Crouse

series ordinal

3

1 reference

17 October 2017

Thomas W Weiss

series ordinal

4

1 reference

17 October 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

American Journal of Cardiology

17 October 2017

1 reference

17 October 2017

92

1 reference

17 October 2017

79-81

1 reference

17 October 2017

1

1 reference

Achieving and maintaining National Cholesterol Education Program low-density lipoprotein cholesterol goals with five statins

17 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900474-0

Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900474-0

Use of simvastatin treatment in patients with combined hyperlipidemia in clinical practice. For the Simvastatin Combined Hyperlipidemia Registry Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900474-0

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900474-0

AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 Update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900474-0

The efficacy of atorvastatin in treating patients with hypercholesterolaemia to target LDL-cholesterol goals: the LIPI-GOAL trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900474-0

Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900474-0

The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900474-0

Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900474-0

Behavioral issues in the efficacy versus effectiveness of pharmacologic agents in the prevention of cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900474-0

Why we need observational studies to evaluate the effectiveness of health care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900474-0

10.1016/S0002-9149(03)00474-0

7 January 2021

Identifiers

DOI

1 reference

17 October 2017

1 reference